Insider Transactions in Q4 2020 at Optimize Rx Corp (OPRX)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2020
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+2.47%
|
-
|
|
Dec 31
2020
|
Gus D Halas Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+1.24%
|
-
|
|
Dec 31
2020
|
Patrick D Spangler Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+3.61%
|
-
|
|
Dec 31
2020
|
Ellen O'Connor Vos Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+2.45%
|
-
|
|
Dec 31
2020
|
Gregory D Wasson Director |
BUY
Grant, award, or other acquisition
|
Direct |
802
+4.51%
|
-
|
|
Dec 31
2020
|
William J Febbo CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,186
+6.74%
|
-
|
|
Nov 12
2020
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+14.19%
|
$30,000
$2.46 P/Share
|
|
Nov 11
2020
|
Douglas P Baker CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
15,000
-16.54%
|
$360,000
$24.05 P/Share
|